CAMBRIDGE, England, April 2022 — Cambridge Nutranostics Ltd, CNL,  has begun validation in the clinic of its first test prototype to assess and monitor plasma oxygen, the part of the total blood O2, which can cross the capillary wall and deliver this essential gas for tissue cell respiration and the target